Cyclooxygenase-2: A new target for epithelial cancer treatments - Arachidonic acid and prostaglandins, inflammation and oncology Journal Article


Authors: Eschwege, P.; de Ledinghen, V.; Camilli, T.; Kulkarni, S.; Dalbagni, G.; Droupy, S.; Jardin, A.; Benoit, G.; Weksler, B. B.
Article Title: Cyclooxygenase-2: A new target for epithelial cancer treatments - Arachidonic acid and prostaglandins, inflammation and oncology
Abstract: Cyclooxygenase pathway: Among the 3 metabolic pathways leading to oxidation of arachidonic acid, the cyclooxygenase (COX) pathway produces prostaglandin CZ that is rapidly transformed into prostaglandin H2. Prostaglandins: Prostaglandins are inflammation mediators that are strongly implicated in tumorgenesis. They participate in tumor initiation, promotion and growth. Inflammation and epithelial cancer: Chronic inflammation is a risk factor for epithelial cancer. It induces prostaglandin synthesis via activation of COX-2. There is a cause and effect relationship between chronic inflammation and carcinogeneis via COX-2 expression. It has been demonstrated that COX-2 favor; tumor invasion and inhibits apoptosis. Tumor growth is favored by PGE2-induced reduction in immunity; COX-2 inhibitors reinforce the immune response. Finally COX-2 is expressed in tumor neovessels and plays a role in angiogenesis (C) 2001, Masson, Paris.
Keywords: angiogenesis; biosynthesis; expression; cells; activation; inhibitors; colon-cancer; human breast-cancer; nonsteroidal antiinflammatory drugs; human; malondialdehyde
Journal Title: Presse Medicale
Volume: 30
Issue: 10
ISSN: 0755-4982
Publisher: Masson Editeur  
Date Published: 2001-03-17
Start Page: 508
End Page: 510
Language: French
ACCESSION: WOS:000167713200012
PROVIDER: wos
Notes: Article -- Source: Wos